Valuation : Steris PLC

Market Cap 22.12B 19.03B 17.86B 16.34B 30.49B 2,091B 30.73B 211B 82.26B 1,068B 83.05B 81.24B 3,441B P/E 2027 *
24.4x
P/E 2028 * 21.7x
Enterprise Value 23.47B 20.2B 18.95B 17.34B 32.36B 2,219B 32.62B 224B 87.31B 1,134B 88.14B 86.22B 3,652B EV / Sales 2027 *
3.68x
EV / Sales 2028 * 3.41x
Free-Float
99.69%
Yield 2027 *
1.17%
Yield 2028 * 1.27%
Manager TitleAgeSince
Chief Executive Officer 53 29/07/2021
Director of Finance/CFO 59 18/08/2025
Compliance Officer - 01/08/2019
Director TitleAgeSince
Director/Board Member 73 01/03/2005
Director/Board Member 54 01/05/2018
Chairman 67 28/07/2018
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%-.--% - - 22.12B
-1.52%-2.51%-17.70%+5.78% 188B
+1.00%+3.48%+0.92%+13.36% 119B
+0.26%+4.98%+14.26%+92.74% 64.35B
-1.31%-1.09%+22.44%+46.84% 52.59B
+0.05%-0.27%-1.05%-32.62% 51.11B
+0.02%+0.47%+13.67%-11.96% 33.85B
+0.80%+5.60% - - 32.1B
+0.03%-0.97%+37.67%-15.93% 24.12B
-1.44%-4.21%-7.37%+11.97% 23.39B
Average -0.04%+0.09%+7.86%+13.77% 65.44B
Weighted average by Cap. -0.30%-0.57%+0.04%+16.04%

Financials

2027 *2028 *
Net sales 6.37B 5.48B 5.15B 4.71B 8.79B 602B 8.86B 60.86B 23.7B 308B 23.93B 23.41B 991B 6.78B 5.83B 5.47B 5.01B 9.34B 641B 9.42B 64.74B 25.21B 327B 25.45B 24.9B 1,054B
Net income 889M 765M 718M 657M 1.23B 84.02B 1.24B 8.49B 3.31B 42.94B 3.34B 3.26B 138B 1.02B 877M 823M 753M 1.41B 96.34B 1.42B 9.73B 3.79B 49.23B 3.83B 3.74B 159B
Net Debt 1.36B 1.17B 1.09B 1B 1.87B 128B 1.88B 12.95B 5.04B 65.51B 5.09B 4.98B 211B 1.02B 879M 824M 754M 1.41B 96.52B 1.42B 9.75B 3.8B 49.33B 3.83B 3.75B 159B
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-